title: Phase II study of lonidamine in metastatic prostatic carcinoma.
authors.affiliation: Ontario Cancer Treatment and Research Foundation Ottawa Regional Cancer Center, Canada.
authors.forename: D J
authors.initials: DJ
authors.lastname: Stewart
authors.forename: S E
authors.initials: SE
authors.lastname: Aitken
authors.forename: A H
authors.initials: AH
authors.lastname: Irvine
authors.forename: D E
authors.initials: DE
authors.lastname: Moors
authors.forename: N G
authors.initials: NG
authors.lastname: Futter
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D004341:Drug Evaluation; D006801:Humans; D007191:Indazoles / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D011471:Prostatic Neoplasms / Q000188:drug therapy*
chemical_list: D000970:Antineoplastic Agents; D007191:Indazoles; C016371:lonidamine